Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations rose 8381.32% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 51492.87%. This contributed to the annual value of -$38.7 million for FY2025, which is 51492.87% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations stood at -$1.1 million, which was up 8381.32% from -$14.8 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations ranged from a high of $14.8 million in Q1 2024 and a low of -$37.0 million during Q2 2023
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations had a median value of -$6.9 million in 2022 and averaged -$6.3 million.
  • Over the last 5 years, Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations had its largest YoY gain of 25478.75% in 2023, and its largest YoY loss of 91754.68% in 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Income from Continuing Operations (Quarter) stood at $7.5 million in 2021, then tumbled by 221.92% to -$9.2 million in 2022, then surged by 254.79% to $14.2 million in 2023, then tumbled by 146.14% to -$6.6 million in 2024, then skyrocketed by 82.54% to -$1.1 million in 2025.
  • Its Income from Continuing Operations stands at -$1.1 million for Q2 2025, versus -$14.8 million for Q1 2025 and -$6.6 million for Q4 2024.